FDA Clearance Tracker · P860026-S009
Avery Diaphragm Pacing System (alson known as Breathing Pacemaker System)
Last checked: Nov 21, 2026Latest source record: Nov 4, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Nov 4, 2019
Approved
Time to decision
768 days
Received Sep 27, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P860026-S009
- Device name
- Avery Diaphragm Pacing System (alson known as Breathing Pacemaker System)
- Applicant
- Avery Biomedical Devices, Inc.
- Applicant location
- Commack, NY
- Received
- Sep 27, 2017
- Decided
- Nov 4, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P860026
Device type
- Device class
- Class III
- Regulation
- 21 CFR 882.5830
FDA's approval statement
As written in FDA's record.
Approval to replace the Mark IV transmitter with the digital Spirit transmitter.
Source documents
Other decisions for Avery Biomedical Devices, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.